147 related articles for article (PubMed ID: 20815110)
1. Atorvastatin for reduction of myocardial damage during angioplasty trials.
Nusca A; Melfi R; Patti G; Di Sciascio G
J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):709-11. PubMed ID: 20815110
[No Abstract] [Full Text] [Related]
2. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
Patti G; Pasceri V; Nusca A; Di Sciascio G
Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
[TBL] [Abstract][Full Text] [Related]
3. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
Patti G; Chello M; Gatto L; Alfano G; Miglionico M; Covino E; Di Sciascio G
J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):795-800. PubMed ID: 20613550
[TBL] [Abstract][Full Text] [Related]
4. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
[TBL] [Abstract][Full Text] [Related]
5. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
Shechter M
Circulation; 2003 Jun; 107(22):e210; author reply e210. PubMed ID: 12796420
[No Abstract] [Full Text] [Related]
7. [The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting].
Han YL; Li CY; Li Y; Kang J; Yan CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):788-92. PubMed ID: 18070466
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
9. Concurrent use of clopidogrel (Plavix) and atorvasatin (Lipitor) is contraindicated.
Chetty N; Naran NH; Munster M
S Afr Med J; 2006 Apr; 96(4):264. PubMed ID: 16670787
[No Abstract] [Full Text] [Related]
10. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the atorvastatin-clopidogrel drug-drug interaction.
Lau WC; Carville DG; Bates ER
Circulation; 2004 Aug; 110(6):e66-7; author reply e66-7. PubMed ID: 15302813
[No Abstract] [Full Text] [Related]
12. Comparison of low vs moderate dose of atorvastatin in clopidogrel resistance after coronary stenting in Korean patients with acute coronary syndrome.
Hong SJ; Park JY; Kim KA; Ahn CM; Park JS; Kim YH; Shim WJ; Park SM; Lim DS
Circ J; 2009 Jun; 73(6):1111-8. PubMed ID: 19372620
[TBL] [Abstract][Full Text] [Related]
13. [Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina].
Shen J; Zhang RY; Zhang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):807-11. PubMed ID: 19102862
[TBL] [Abstract][Full Text] [Related]
14. Potential statin-clopidogrel interaction requires more study.
Williams D; Ford I; Hawksworth G
Circulation; 2004 Aug; 110(6):e68; author reply e68. PubMed ID: 15302814
[No Abstract] [Full Text] [Related]
15. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
Bloom JM
N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
[No Abstract] [Full Text] [Related]
16. Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).
Poyet R; Cuisset T; Frere C; Quilici J; Gaborit B; Moro PJ; Camoin L; Morange PE; Bonnet JL; Alessi MC
Thromb Res; 2010 Nov; 126(5):e397-9. PubMed ID: 20825983
[No Abstract] [Full Text] [Related]
17. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies.
Wienbergen H; Gitt AK; Schiele R; Juenger C; Heer T; Meisenzahl C; Limbourg P; Bossaller C; Senges J;
Am J Cardiol; 2003 Aug; 92(3):285-8. PubMed ID: 12888133
[TBL] [Abstract][Full Text] [Related]
18. The year in non-ST-segment elevation acute coronary syndromes.
Giugliano RP; Braunwald E
J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
[No Abstract] [Full Text] [Related]
19. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction.
Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C
J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203
[TBL] [Abstract][Full Text] [Related]
20. Prevention of myocardial damage during coronary intervention.
Pasceri V; Patti G; Di Sciascio G
Cardiovasc Hematol Disord Drug Targets; 2006 Jun; 6(2):77-83. PubMed ID: 16787193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
